Unlock instant, AI-driven research and patent intelligence for your innovation.

Carbapenem derivatives

A representative compound technology, applied in the field of medicine, can solve problems such as low clinical utilization, failure to meet clinical needs, and increased bacterial resistance

Active Publication Date: 2009-04-22
XUANZHU BIOPHARMACEUTICAL CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Due to the continuous increase of bacterial resistance due to the abuse of antibiotics, and the limitation of digestive tract absorption, the currently marketed carbapenems can only be administered as injections in clinical practice, and the clinical utilization is not high. The half-life of penem is relatively short, which can no longer meet the clinical needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbapenem derivatives
  • Carbapenem derivatives
  • Carbapenem derivatives

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0117] Example 1 (2S, 4S)-4-mercapto-2-formyl [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-tri Azin-3-yl)amine Preparation of base]-1-(tert-butoxycarbonyl)pyrrolidine

[0118] 14.5 g (50 mmol) of (2S,4S)-4-acetylthio-2-carboxy-1-(tert-butoxycarbonyl)pyrrolidine and 200 ml of anhydrous tetrahydrofuran were added to the dry reaction flask. Under nitrogen protection, 13g (80mmol) of 1,1-carbonyldiimidazole was added at room temperature, reacted for 1h, and 11.4g (80mmol) of 3-amino-2-methyl-5,6-dioxo- 1,2-dihydro-1,2,4-triazine in 100ml tetrahydrofuran solution, continue to react for 1h. Then 100ml of 1mol / l hydrochloric acid was added dropwise, extracted with ethyl acetate (100ml×2), the organic phase was washed with water and saturated sodium chloride solution successively, concentrated under reduced pressure, the residue was added with 100ml of 4mol / l hydrochloric acid, stirred for 2h, and The dilute alkali solution was adjusted to be alkaline, and a solid was precipita...

Embodiment 2

[0119] Example 2 (4R, 5S, 6S)-3-[(2S, 4S)-2-formyl[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro- 1,2,4-triazin-3-yl) Amino]-1-(tert-butoxycarbonyl)pyrrolidin-4-yl]thio-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[ 3.2.0] Hept-2- Preparation of ene-2-carboxylic acid p-nitrobenzyl ester

[0120] In a dry reaction flask, add (4R, 5S, 6S)-3-diphenoxyphosphoryloxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1- Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid p-nitrobenzyl ester 23.8g (40mmol) in 200ml of acetonitrile solution, cooled to below 0 ℃, add diisopropylethylamine 10ml and (2S ,4S)-4-mercapto-2-formyl[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl )Amino]-1-(tert-butoxycarbonyl)pyrrolidine 16.7g (45mmol) in 100ml of acetonitrile, stirred at 0°C for 15h. After the reaction was completed, 500 ml of ethyl acetate was added to dilute, washed with water and saturated brine successively, the organic layer was dried and concentrated to obtain 16.7 g of yellow solid, ...

Embodiment 3

[0121] Example 3 (4R, 5S, 6S)-3-[(2S, 4S)-2-formyl[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro- 1,2,4-triazin-3-yl) Amino]-pyrrolidin-4-yl]thio-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2- Preparation of ene-2-carboxylic acids prepare

[0122] (4R, 5S, 6S)-3-[(2S, 4S)-2-formyl[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1, 2,4-Triazin-3-yl)amino]-1-(tert-butoxycarbonyl)pyrrolidin-4-yl]thio-6-[(1R)-1-hydroxyethyl]-4-methyl 14.3g (20mmol) of p-nitrobenzyl 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate was dissolved in 100ml of dichloromethane, and 20ml of anisole and nitric acid were added Add 1 mol / L aluminum trichloride nitromethane solution 100ml dropwise at -50°C, stir for 2 hours at -40°C, add 200ml of water, precipitate a solid, filter, and dissolve the filter cake in 400mlTHF and 30ml of water Add 3 g of 10% palladium-carbon to the mixture, stir and react for 2 h at 40° C. under 4 MPa hydrogen pressure, filter off palladium-carbon, add THF 150 ml to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, in particular to a carbapenems derivative shown in a general formula (1), pharmaceutically acceptable salts, easily hydrolysable esters or isomers thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5> and R<6> are defined in the specification. The invention also relates to a method for preparing the compounds, medical compositions containing the compounds, and application of the compounds to the preparation of medicines for treating and / preventing infectious diseases.

Description

1. Technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to new carbapenem derivatives, pharmaceutically acceptable salts thereof, easily hydrolyzed esters or isomers thereof, preparation methods of these compounds, and medicines containing these compounds Compositions, and the use of these compounds in the preparation of medicines for treating and / or preventing infectious diseases. 2. Background technology [0002] Carbapenem antibiotics are a class of β-lactam antibiotics developed in the 1970s. It has attracted much attention because of its broad antibacterial spectrum, strong antibacterial activity, and stability to β-lactamase. Its structural feature is that the sulfur at the 1-position of the penicillane core is replaced by carbon, and the 2-position has a double bond, which combines the five-membered ring of penicillin and the conjugated double bond of cephalosporin to activate the β-lactam ring. [0003] Drugs of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D477/20A61K31/53A61K31/407A61P31/04
CPCY02P20/55
Inventor 黄振华
Owner XUANZHU BIOPHARMACEUTICAL CO LTD